Purpose
To assess the efficacy of warfarin in reducing stroke and other systemic embolisms in non-valvular atrial fibrillation (AF)
References
Connolly SJ, Laupacis A, Gent M, et al: Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991,
18:349–355.
Laupacis A, Sullivan K: Canadian Atrial Fibrillation Anticoagulation Study: were the patients subsequently treated with
warfarin?. Can Med Assoc J 1996, 154:1669–1674.
|
Farmacêutica